ArticleBMC primary care2025
What motivates primary care providers to prescribe mifepristone medication abortion? Results of a qualitative investigation in Canada.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMifepristone-misoprostol, the gold standard medication abortion drug regimen, became available in Canada in 2017. However, there is limited evidence regarding the factors that influence primary care providers to begin prescribing medication abortion. We aimed to explore perspectives of the behavioural, social, and system factors that influence implementation of medication abortion prescribing among primary care providers in Canada.
methodsWe led a qualitative investigation involving one-on-one interviews with primary care providers who were interested in becoming or already were low-volume medication abortion prescribers in Canada. We collected data at two time points: (1) in 2018 after the first year of mifepristone's availability and (2) in 2023. We recruited participants through partner health organizations' online platforms and listservs. We conducted reflexive thematic analysis to understand resolved, novel, and ongoing factors influencing the implementation of mifepristone in primary care and mapped our results to Diffusion of Innovation theory.
resultsWe completed 18 interviews with primary care providers from across Canada. We identified 5 core Diffusion of Innovation factors that were important to primary care provider implementation of medication abortion care. These factors included adoption and assimilation (motivation), where prescriber pro-choice attitudes and commitment to provide abortion as part of generalist primary care were facilitators. The innovation (knowledge required to use it) and implementation (external collaboration) were interrelated constructs: after training in the knowledge and skills to offer medication abortion, prescribers needed ongoing collaboration and support with physician and pharmacist peers. System antecedents (a receptive context for change) included challenges with abortion-related stigma and harassment in professional and community settings. Finally, system readiness (dedicated time and resources) was necessary to ensure ease in the logistics of medication abortion care, including billing, counseling, and delays in timely care.
conclusionsOur results highlight that, after five years, barriers still exist to providing mifepristone medication abortion in Canadian primary care. We illustrate the importance of addressing ongoing perceptions of logistical barriers to care, concerns about advertising abortion services to the community, and the need for robust mentorship and consultation pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.